Cargando…

Case Fatality of Patients With Type 1 Diabetes After Myocardial Infarction

OBJECTIVE: Type 1 diabetes is a risk factor for myocardial infarction (MI). We aimed to evaluate the case fatality in patients with type 1 diabetes after MI. RESEARCH DESIGN AND METHODS: Consecutive patients experiencing MI with type 1 diabetes (n = 1,935; 41% female; mean age 62.5 years) and withou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerola, Anne M., Juonala, Markus, Palomäki, Antti, Semb, Anne Grete, Rautava, Päivi, Kytö, Ville
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2022
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274223/ https://www.ncbi.nlm.nih.gov/pubmed/35679070 http://dx.doi.org/10.2337/dc22-0042

Ejemplares similares

Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction
por: Kerola, Anne M., et al.
Publicado: (2022)

Sex Differences in Cardiovascular Outcomes of Older Adults After Myocardial Infarction
por: Kerola, Anne M., et al.
Publicado: (2021)

Patients with rheumatoid arthritis have impaired long-term outcomes after myocardial infarction: a nationwide case-control registry study
por: Palomäki, Antti, et al.
Publicado: (2021)

Sex Difference in the Case Fatality of Older Myocardial Infarction Patients
por: Kytö, Ville, et al.
Publicado: (2021)

Acute myocardial infarction or acute myocarditis? Discharge registry-based study of likelihood and associated features in hospitalised patients
por: Kytö, Ville, et al.
Publicado: (2015)

Outcome of acute myocardial infarction versus stable coronary artery disease patients treated with coronary bypass surgery
por: Malmberg, Markus, et al.
Publicado: (2020)

Prognosis After First-Ever Myocardial Infarction in Type 1 Diabetes Is Strongly Affected by Chronic Kidney Disease
por: Smidtslund, Patrik, et al.
Publicado: (2023)

Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation
por: Kytö, Ville, et al.
Publicado: (2022)

Longitudinal Change in Fasting Blood Glucose and Myocardial Infarction Risk in a Population Without Diabetes
por: Jin, Cheng, et al.
Publicado: (2017)

The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial
por: Lexis, Chris P H, et al.
Publicado: (2015)

Likelihood and Predictors of ST-Elevation in Patients Hospitalized for Myocardial Infarction
por: Kytö, Ville, et al.
Publicado: (2014)

Initial statin dose after myocardial infarction and long-term cardiovascular outcomes
por: Kytö, Ville, et al.
Publicado: (2022)

Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial
por: Ajjan, Ramzi A., et al.
Publicado: (2023)

Gender-specific and age-specific differences in unstable angina pectoris admissions: a population-based registry study in Finland
por: Kytö, Ville, et al.
Publicado: (2015)

Long-term outcomes after coronary artery bypass surgery in patients with rheumatoid arthritis
por: Malmberg, Markus, et al.
Publicado: (2021)

Long-Term Outcomes of Surgical Aortic Valve Replacement in Patients with Rheumatoid Arthritis
por: Malmberg, Markus, et al.
Publicado: (2021)

Motivational Interview to improve vascular health in Adolescents with poorly controlled type 1 Diabetes (MIAD): a randomized controlled trial
por: Pulkkinen, Mari-Anne, et al.
Publicado: (2020)

CD36 inhibition partially attenuates myocardial injury in diabetic rats with ischemic postconditioning
por: Zhang, Yuan, et al.
Publicado: (2022)

Polygenic Prediction of Type 2 Diabetes in Africa
por: Chikowore, Tinashe, et al.
Publicado: (2022)

Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
por: Birukov, Anna, et al.
Publicado: (2022)

Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
por: Sveen, Kari Anne, et al.
Publicado: (2021)

Incidence of type 2 diabetes in familial combined hyperlipidemia
por: Brouwers, Martijn C G J, et al.
Publicado: (2020)

Management of type 2 diabetes in chronic kidney disease
por: Triozzi, Jefferson L, et al.
Publicado: (2021)

Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study
por: Shah, Amy S., et al.
Publicado: (2017)

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

Value of Urinary Albumin-to-Creatinine Ratio as a Predictor of Type 2 Diabetes in Pre-Diabetic Individuals
por: Friedman, Allon, et al.
Publicado: (2008)

Association of Intrauterine Exposure to Maternal Diabetes and Obesity With Type 2 Diabetes in Youth: The SEARCH Case-Control Study
por: Dabelea, Dana, et al.
Publicado: (2008)

Adipokines and Incident Type 2 Diabetes in a Canadian Aborigine Population: The Sandy Lake Health and Diabetes Project
por: Ley, Sylvia H., et al.
Publicado: (2008)

Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
por: Soliman, Elsayed Z., et al.
Publicado: (2017)

Serum levels of mac-2 binding protein are associated with diabetic microangiopathy and macroangiopathy in people with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
por: Lomonaco, Romina, et al.
Publicado: (2016)

Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2020)

Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
por: Matsumoto, Chisa, et al.
Publicado: (2022)

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
por: Rossing, Peter, et al.
Publicado: (2022)

Developing a health economic model for Asians with type 2 diabetes based on the Japan Diabetes Complications Study and the Japanese Elderly Diabetes Intervention Trial
por: Tanaka, Shiro, et al.
Publicado: (2021)

Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register
por: Cederholm, Jan, et al.
Publicado: (2008)

Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes
por: Tang, Xin, et al.
Publicado: (2022)

Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
por: Chowdhury, Mahin, et al.
Publicado: (2021)

Pre-diabetes, diabetes and fluctuations of glucose tolerance after gestational diabetes mellitus: 5-year follow-up of a contemporary, prospective study in Germany
por: Haschka, Stefanie J, et al.
Publicado: (2022)

Pitfalls in the Measurement of the Nocturnal Blood Pressure Dip in Adolescents with Type 1 Diabetes
por: Delaney, Angela, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ln6t8to8e3dfirjr4heekck0j8